Top
Skip to Content
LOGO(small) - Queen's University Belfast
  • Our twitter
  • Our facebook
  • Our
  • Our
LOGO(large) - Queen's University Belfast

Wellcome-Wolfson Institute For Experimental Medicine

  • Home
  • Our Research
    • Research Themes
    • Find a PhD Supervisor
  • Our People
    • Key Contacts
    • Academic Staff
    • Fellows
    • Research Staff
    • Technical Staff
    • Administrative/Clerical Staff
    • Emeritus Professors
    • Opportunities
    • Visiting Students
  • Our Place
    • Facilities
    • Seminar Series
    • The Barcroft Lecture
    • Fraser Symposium
    • Green Impact
  • Education and Training
    • Postgraduate Degrees
    • Masters in Experimental Medicine
    • Undergraduate Degrees
    • Summer Student Programme
    • iENGAGE
    • Postdoctoral Development Programme
    • Outreach
    • Bioinformatics Service
  • News
    • WWIEM Newsletter
  • Innovation
  • Impact
  • COVID-19
  • Donate
  • Home
  • Our Research
    • Research Themes
    • Find a PhD Supervisor
  • Our People
    • Key Contacts
    • Academic Staff
    • Fellows
    • Research Staff
    • Technical Staff
    • Administrative/Clerical Staff
    • Emeritus Professors
    • Opportunities
    • Visiting Students
  • Our Place
    • Facilities
    • Seminar Series
    • The Barcroft Lecture
    • Fraser Symposium
    • Green Impact
  • Education and Training
    • Postgraduate Degrees
    • Masters in Experimental Medicine
    • Undergraduate Degrees
    • Summer Student Programme
    • iENGAGE
    • Postdoctoral Development Programme
    • Outreach
    • Bioinformatics Service
  • News
    • WWIEM Newsletter
  • Innovation
  • Impact
  • COVID-19
  • Donate
  • Our twitter
  • Our facebook
  • Our
In This Section

  • Home
  • Wellcome-Wolfson Institute For Experimental Medicine
  • Innovation

Innovation

D2_030_Research_2V

Innovation is a key aspect of WWIEM’s activity.  Translation of our research into innovative therapeutics to improve patient outcomes is central to our research endeavours.

Our approach to innovation is twofold:

  • We engage and collaborate with the leading industrial partners in the biotechnology, pharma development and medical diagnostics industries;
  • We support the creation of new companies that pursue our goal of improving patient outcomes.

Since 2015, we have developed more than 30 projects and collaborations with different biopharma industrial partners.  These projects demonstrate our engagement with industry and represent our commitment to be at the forefront of industrial developments in the biopharma sector.  Our industrial partners include, among others, GlaxoSmithKline, Pfizer, AstraZeneca, Novartis Pharma, Boehringer Ingelheim Pharma, Basilea Pharmaceutica, Randox Laboratories, Celerion, Novaliq; Novo Nordisk and F. Hoffmann-La Roche.

The Institute actively contributes to the success of spinout companies created by our researchers and provides access to our world-class facilities for the initial stages of the company.  New spinout companies include VacVersa.

Industrial collaborations and initiatives are supported by our Business Development Manager, Dr Macu Higueras (i.higueras@qub.ac.uk).

 

Home
  • Home
  • Our Research
  • Our People
  • Our Place
  • Education and Training
  • News
  • Innovation
  • Impact
  • COVID-19
  • Donate
Queen's University Belfast - Logo (small)
Contact Us

Wellcome-Wolfson Institute For Experimental Medicine

School of Medicine, Dentistry and Biomedical Sciences
Queen's University Belfast
97 Lisburn Road
Belfast
BT9 7BL

Tel: (+44) 028 9097 1643
Email: wwiem@qub.ac.uk

Quick Links

  • Home
  • Our Research
  • Our People
  • Our Place
  • Education and Training

 

© Queen's University Belfast 2023
Privacy and cookies
Website accessibility
Freedom of information
Modern slavery statement
Equality, Diversity and Inclusion
Manage cookies